Noble Romans (NROM) EBITDA Margin (2010 - 2025)

Noble Romans' EBITDA Margin history runs 15 years deep, the most recent figure standing at 3.81% for Q4 2025.

• On a quarterly basis, EBITDA Margin rose 197.0% year-over-year to 3.81% in Q4 2025; TTM through Dec 2025 was 14.61%, a 488.0% increase from a year earlier, with the FY2025 full-year figure at 14.61%, up 488.0% from the prior year.
• EBITDA Margin was 3.81% for Q4 2025 at Noble Romans, down from 19.77% in the prior quarter.
• Over the last five years, EBITDA Margin for NROM reached as high as 35405.24% in Q1 2021 and fell as low as 11.87% in Q4 2022.
• A 5-year average of 2757.35% and a median of 13.54% in 2023 frame the typical range for EBITDA Margin.
• The widest annual swing landed in 2021, when EBITDA Margin jumped 3538358 bps; it then plunged 3540065 bps in 2022.
• Tracing NROM's EBITDA Margin over 5 years: stood at 2.95% in 2021, then plunged by 302 bps to 11.87% in 2022, then surged by 276 bps to 20.87% in 2023, then slumped by 91 bps to 1.85% in 2024, then jumped by 107 bps to 3.81% in 2025.
• According to Business Quant data, EBITDA Margin over the past three periods registered 3.81%, 19.77%, and 22.4% for Q4 2025, Q3 2025, and Q2 2025 respectively.